Three to four years outcomes of the absorb bioresorbable vascular scaffold versus second‐generation drug‐eluting stent: A meta‐analysis-Reference-Cited by-同舟云学术

Three to four years outcomes of the absorb bioresorbable vascular scaffold versus second‐generation drug‐eluting stent: A meta‐analysis

Published:2019-04-19 Issue:2 Volume:95 Page:216-223
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Goel Sunny¹^ORCID,Pasam Ravi Teja¹,Chava Srilekha¹,Sharma Abhishek²^ORCID,Malik Bilal Ahmad¹,Ayzenberg Sergey¹,Frankel Robert¹,Shani Jacob¹,Gidwani Umesh³

Affiliation:

1. Department of CardiologyMaimonides Medical Center Brooklyn New York

2. Department of CardiologyRush University Medical Center Chicago Illinois

3. Department of CardiologyIcahn School of Medicine at Mount Sinai New York New York

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.28290

Reference34 articles.

1. Impact of the Everolimus-Eluting Stent on Stent Thrombosis

2. Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease

3. A Next-Generation Bioresorbable Coronary Scaffold System: From Bench to First Clinical Evaluation

4. Bioresorbable stents: The future of interventional cardiology?

5. 1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring new insights in coronary lesion assessment and treatment in patients with diabetes mellitus: the impact of optical coherence tomography;Cardiovascular Diabetology;2023-05-24

2. Five-year clinical outcomes using the bioresorbable vascular scaffold: Insights from the FRANCE ABSORB registry;Archives of Cardiovascular Diseases;2022-10

3. Stent Selection for Primary Angioplasty and Outcomes in the Era of Potent Antiplatelets. Data from the Multicenter Randomized Prague-18 Trial;Journal of Clinical Medicine;2021-10-30

4. Absorb BRS for in-stent restenosis: the final bow before (scaffold) collapse?;Open Heart;2021-10

5. Five‐year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus‐eluting coronary stents with everolimus‐eluting bioresorbable vascular scaffolds;Catheterization and Cardiovascular Interventions;2021-06-26